{"text": "Differences in FHIT expression levels between AC, LCC and SCC indicated the usefulness of this gene as a diagnostic marker for NSCLC subtype differentiation. FHIT promoter hypermethylation both in cancer and control tissue indicated the presence of epigenetic alterations in early stage of NSCLC development. Differences in gene promoter methylation between cancer patients with and without node infiltration might be considered as a prognostic marker.", "denotations": [{"id": "T1", "obj": "gene", "span": {"begin": 15, "end": 19}}, {"id": "T2", "obj": "disease", "span": {"begin": 50, "end": 53}}, {"id": "T3", "obj": "disease", "span": {"begin": 58, "end": 61}}, {"id": "T4", "obj": "disease", "span": {"begin": 127, "end": 132}}, {"id": "T5", "obj": "disease", "span": {"begin": 197, "end": 203}}, {"id": "T6", "obj": "disease", "span": {"begin": 358, "end": 373}}]}
